Self-promoted tumor-targeting nanomedicine activates STING-driven antitumor immunity via photodynamic DNA damage and PARP inhibition

*


Corresponding authors

^a



The Fifth Affiliated Hospital, Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, The NMPA and State Key Laboratory of Respiratory Disease, The School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, P. R. China



E-mail:
lisy-sci@gzhmu.edu.cn

^b



Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore



E-mail:
chen.shawn@nus.edu.sg

^c



Department of Chemical and Biomolecular Engineering, College of Design and Engineering, National University of Singapore, Singapore

^d



Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore

^e



Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore

^f



Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

^g



Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

^h



Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, Singapore

ⁱ



Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research (A*STAR), Singapore